02268 News
CMBI Ratings and Target Prices for Pharmaceuticals (Table)
CMBI Anticipates Ongoing Trend in Innovative Drug Exports, Assigns Buy Ratings to SINO BIOPHARM, WUXI XDC, and Others
Nomura Reports WUXI APPTEC (02359.HK) Exceeds Expectations in 4Q25; Anticipates Continued Growth This Year
UBS Maintains Buy Rating on WUXI XDC as Last Year's New Projects Exceed Expectations
Jefferies Anticipates Earnings Growth Will Drive Returns in CN A-Shares; New Additions Include SYTECH and HIMILE SCIENCE & TECHNOLOGY
<Outlook>CCBI and SPDBI's Preferred Hong Kong Stocks (Table)
CMBI Ratings and Target Prices for Pharmaceutical Companies (Table)
CMBI Suggests 3SBIO, Interpreting Pharma Sector Decline as a Reassessment of Industry Valuation and Performance
02268 Events
No data
02268 Monitor News
No data
02268 Earnings Analysis